Last update Oct. 24, 2022
Compatible
We do not have alternatives for Indian Senna, Tinnevelly Senna since it is relatively safe.
Suggestions made at e-lactancia are done by APILAM team of health professionals, and are based on updated scientific publications. It is not intended to replace the relationship you have with your doctor but to compound it. The pharmaceutical industry contraindicates breastfeeding, mistakenly and without scientific reasons, in most of the drug data sheets.
Your contribution is essential for this service to continue to exist. We need the generosity of people like you who believe in the benefits of breastfeeding.
Thank you for helping to protect and promote breastfeeding.
Indian Senna, Tinnevelly Senna is also known as Senna. Here it is a list of alternative known names::
Indian Senna, Tinnevelly Senna in other languages or writings:
Indian Senna, Tinnevelly Senna belongs to these groups or families:
Main tradenames from several countries containing Indian Senna, Tinnevelly Senna in its composition:
Variable | Value | Unit |
---|---|---|
Oral Bioavail. | 0 | % |
Molecular weight | 863 | daltons |
Theoretical Dose | 0.0041 | mg/Kg/d |
Relative Dose | 0.24 | % |
Write us at elactancia.org@gmail.com
e-lactancia is a resource recommended by Academy of Breastfeeding Medicine - 2015 of United States of America
Would you like to recommend the use of e-lactancia? Write to us at corporate mail of APILAM
It is an anthraquinone stimulant laxative. It is extracted from the leaves, fruits and flowers of the bush known as Senna, Sen, Sen of Alexandria, Indian Senna or Tinnevelly Senna. It contains anthraquinones, naphtoquinones, flavonoids, mineral salts, polysaccharides (mucilage). Used to treat constipation and for bowel movement before diagnostic procedures or surgery. Oral administration.
Practically nothing is absorbed in the digestive tract and the high molecular weight of sennoside makes it difficult for it to pass into breast milk, which explains why levels have not been found in breast milk or have been insignificant (Faber 1989 & 88, Werthmann 1973) and no problems have been observed in infants whose mothers were taking it. (Faber 1988, Shelton 1980, Baldwin 1963, Duncan 1957)
There is a risk of hepatotoxicity if prolonged or excessive use. (Bunchorntavakul 2013)
Several medical societies and expert authors consider the use of this medication compatible with breastfeeding. (Briggs 2015, Nice 2000, Hagemann 1998, Gattuso 1994)
American Academy of Pediatrics: Maternal Medication Usually Compatible With Breastfeeding (AAP 2001). Eleventh WHO Model List of Essential Drugs 2002: Compatible with breastfeeding. (WHO 2002)